10 years developing the drug is not quick... The trial is FDA sanctioned. EBC-46 is the real deal. Their other lead drug WH1 (wound healing) is the one raising eyebrows and potentially be the blockbuster.
QBiotics v Cellmid, page-7
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable